Emergence Of New Diseases Prospering The Growth Of Pharmaceutical Packaging In Middle East And Africa (Mea)
- Vikas Kumar
- September 7, 2021
- PHARMACEUTICALS
- 0 Comments
Middle East & Africa (MEA) Pharmaceutical Packaging Market is expected to exceed the market valuation of more than US$ 13,265.7 million by 2028 expanding at a reasonable CAGR of around 8% during the forecast period (2021-2028). Pharmaceutical Packaging is mainly done using drug-compatible materials to provide protection, presentation, identification, information, compliance, convenience, integrity, and stability of the product. Pharmaceutical packaging is made by using a variety of materials such as plastics & polymers, paper and paperboard, glass, aluminum foil, and others. In the African region, the technologies are creating several opportunities to leapfrog in the Healthcare Sector, as revealed by the United Nations Industrial Development Organization.
The demand for Middle East & Africa (MEA) pharmaceutical packaging market is increasing on account of the opening of production facilities in the region, advanced manufacturing processes, sterilized tracking, and tracing of drugs, rising genetic drug market, emerging growth in the Drug Delivery market, increase in R&D initiatives, and increase in the prevalence of chronic diseases coupled with the aging population. The World Bank projects that the U.A.E.’s population will grow from 9.4 million people in 2017 to 11.055 million by 2030.
For a detailed analysis of the market drivers in Middle East & Africa (MEA) pharmaceutical packaging market browse through – https://univdatos.com/report/mea-pharmaceuticals-packaging-market
The COVID-19 pandemic is causing a worldwide concern and economic deprivation of business all over the world. There is a mixed impact of the pandemic on the pharmaceutical packaging industry in the MEA region, and it depends on its various end-users. Since, the start of the COVID-19 pandemic, demand for certain packaging in the Middle East region is very high. There is an increase in the requirement for pharmaceutical glass packaging while the recycling industry struggles to maintain operations during the outbreak. Some MEA pharmaceutical packaging companies are opting for automation across their operations as it can address most of the challenges that COVID-19 is placing in the path of smooth, safe, and cost-effective operations.
Based on Material Type, the market is bifurcated into Plastics & polymers, Paper and paperboard, Glass, and Aluminum foil, and others. The demand for the plastic & polymers segment is increasing owing to the increase in the use of PVC, polypropylene, polycarbonate, polyethylene terephthalate, and high-thickened polyethylene in the packaging for pharmaceutical purposes due to its lightweight, low cost, good barrier properties, and strength. For instance, Mpact is one of the leading plastic packaging manufacturers in Johannesburg (southern Africa). The company collects around 624,000 tonnes of plastic recyclables from pre-and post-consumer sources. Also, the liquid packaging recycling plant recycles 24,000 tonnes of used liquid cartons a year, saving 65,240 cubic meters of landfill space and 11,400 tonnes of carbon emissions.
For a detailed analysis of Material Type in Middle East & Africa (MEA) pharmaceutical packaging market browse through – https://univdatos.com/report/mea-pharmaceuticals-packaging-market
Based on by product type, the market is bifurcated into primary pharmaceutical packaging, secondary pharmaceutical packaging, and tertiary pharmaceutical packaging. The primary pharmaceutical packaging is further bifurcated into plastic bottles, caps & closures, parenteral containers, blister packs, prefillable inhalers, and others. The primary pharmaceutical packaging is the most prominent section in the MEA market owing to the storage of medicines with no damage. The secondary pharmaceutical packaging is further bifurcated into prescription containers and pharmaceutical packaging accessories. The components in the primary pharmaceutical packaging are in direct contact with the product e.g., bottle vials, blisters whereas the components in the secondary pharmaceutical packaging are not in direct contact with the product e.g., cardboard boxes and aluminum caps. The choice of the materials used in the primary or secondary packaging will rely on the degree of protection required, compatibility of API (Active Pharmaceutical Ingredient) and Excipients with the packaging material, filling method, presentation for over-the-counter (OTC) drugs, and convenience for the user. Frank Noe Egypt (serving the market since 1985) is the most reputed company for pharma packaging manufacturing which has the ability of manufacturing tamper-proof packaging, childproof tablet containers, and self-desiccant capsule packaging.
For a detailed analysis of Product Type in Middle East & Africa (MEA) pharmaceutical packaging market browse through – https://univdatos.com/report/mea-pharmaceuticals-packaging-market
Based on end-user, the market is bifurcated into contract packaging, pharmaceutical manufacturing, retail pharmacy, institutional pharmacy and others. Pharmaceutical Manufacturing is anticipated to show the highest growth in the market in the forecast period owing to the growing focus on outsourcing the packaging activities to save time as well as packaging costs. In April 2019, GlaxoSmithKline (GSK) announced its partnership with Neopharma to localize its Secondary Packaging stage (the last phase of the manufacturing process) before distribution and sale. This partnership reduced the manufacturing process time to only three months, offering UAE patients faster access to the widely prescribed medicines.
For a better understanding of the market adoption of Pharmaceutical Packaging in the Middle East and Africa region, detailed country-level analysis is conducted for major countries including (UAE, Saudi Arabia, Qatar, Turkey, Egypt, South Africa, Nigeria, and the Rest of the Middle East and Africa). The Saudi Arabia subsegment is expected to dominate the market in the upcoming period owing to the changing population dynamics, rising prevalence of non-communal diseases such as cardiovascular disease, cancer, diabetes, and several initiatives taken by the government in the region. Sunpack Packaging Systems (FZC), incorporated in the Sharjah airport International in UAE is engaged in the plastic container manufacturing business by acquisition of 89% of the shares in ‘Sunpack’ for manufacturing pharmaceutical packaging products in 2019.
Request for Sample of the report browses through – https://univdatos.com/request_form/form/429
Some of the major players operating in the market include CCL Industries Inc., Intrapac Group, Rexam PLC, Schott AG, MeadWestvaco Corporation, Nypro Inc., Aptar Group Inc., Wihuri Group, and Gerresheimer AG. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.
Global Middle East & Africa (MEA) pharmaceutical packaging market Segmentation
Market Insight, by Material Type
- Plastics & Polymers
- Paper and Paperboard
- Glass
- Aluminum Foil
- Others
Market Insight, by Product Type
- Primary Pharmaceutical Packaging
- Plastic Bottles
- Caps & Closures
- Parenteral Containers
- Blister Packs
- Prefillable Inhalers
- Others
- Secondary Pharmaceutical Packaging
- Prescription Containers
- Pharmaceutical Packaging Accessories
- Tertiary Pharmaceutical Packaging
Market Insight, by End-User
- Contract Packaging
- Pharmaceutical Manufacturing
- Retail Pharmacy
- Institutional Pharmacy And Others
Market Insight, by Region
- Middle East and Africa
- UAE
- Saudi Arabia
- Qatar
- Turkey
- Egypt
- South Africa
- Rest of the Middle East and Africa
Top Company Profiles
- Amcor Ltd.
- CCL Industries Inc.
- Intrapac Group
- Schott AG
- WestRock
- Jabil Inc.
- West Pharmaceutical Services, Inc.
Related Posts
